Should avatrombopag (Sucoxin) be taken for life?

Avatrombopag is a thrombopoietin receptor agonist mainly used to treat thrombocytopenia. It is particularly indicated for use in adult patients with chronic liver disease-related thrombocytopenia scheduled for elective diagnostic procedures or surgery.

Whether avatrombopag (Sucoxin) needs to be taken for life cannot be generalized. It depends on the patient's physical condition, severity of illness, and sensitivity to medications. The administration time and cycle of avatrombopag are determined according to the patient's specific condition. For thrombocytopenia associated with chronic liver disease, it is usually started 10 to 13 days before elective invasive testing or surgery. For primary immune thrombocytopenia, the starting dose is 20 mg per day, and the maximum dose can reach 40 mg per day.

Whether avatrombopag needs to be taken for life mainly depends on the individual differences of the patient and the development of the disease. Some patients may be able to return their platelet count to normal levels after taking avatrombopag for a short period of time, and may not need to continue taking the drug thereafter. However, for some patients with more complex or severe conditions, long-term or even lifelong use may be required to maintain the stability of platelet counts.

All medications should be used under the guidance of a physician, and patients should not decide to stop or continue taking medications on their own. Regular platelet count checks and evaluation by your doctor are key to determining whether continued medication is needed.

In summary, there is no fixed answer to whether avatrombopag needs to be taken for life. It depends on the patient's specific situation and the doctor's guidance. Therefore, when using avatrombopag, patients should maintain close communication with their doctors and adjust their medication regimen according to their doctors' recommendations.